Published in Women's Health Weekly, January 15th, 2004
The grant supports the efforts of SBRI's Malaria Antigen Discovery (MAD) program to develop a pregnancy malaria vaccine, which has the potential to protect millions of pregnant women and their unborn children each year.
The grant from the Gates Foundation enables SBRI to expand research efforts to identify optimal antigens for inclusion in a multicomponent vaccine that would prevent malaria during pregnancy. All candidate antigens for a pregnancy malaria vaccine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.